A quantitative and selective oxidation using Gluconobacter oxydans is the key step in a synthesis of 1-deoxynojirimycin (1) starting from glucose; derivatives of (1) are of interest as inhibitors of intestinal α-glucosidases in the treatment of carbohydrate-dependent metabolic disorders.
No takes yet. Share an insight, caveat, or question.
Kinast et al. (1981) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: